齋藤良太 (RYOTA SAITO) - マイポータル

基本情報

J-GLOBAL ID: 202001017418706062
researchmap会員ID: R000011836

論文

Histological and genetic features and therapeutic responses of lung cancers explored via the global analysis of their metabolome profile.

Daisuke Narita, Eiji Hishinuma, Risa Ebina-Shibuya, Eisaku Miyauchi, Naomi Matsukawa, Ikuko N Motoike, Kengo Kinoshita, Seizo Koshiba, Yoko Tsukita, Hirotsugu Notsuda …

Lung cancer (Amsterdam, Netherlands) 200 108082-108082 2025年2月
Peripheral blood biomarkers associated with combination of immune checkpoint blockade plus chemotherapy in NSCLC.

Nozomu Kimura, Yoko Tsukita, Risa Ebina-Shibuya, Eisaku Miyauchi, Mitsuhiro Yamada, Daisuke Narita, Ryota Saito, Chihiro Inoue, Naoya Fujino, Tomohiro Ichikawa …

Cancer biomarkers : section A of Disease markers 2024年3月20日
Monitoring of Plasma EGFR Mutations during Osimertinib Treatment for NSCLC Patients with Acquired T790M Mutation.

Kana Watanabe, Ryota Saito, Eisaku Miyauchi, Hiromi Nagashima, Atsushi Nakamura, Shunichi Sugawara, Nobuyuki Tanaka, Hiroshi Terasaki, Tatsuro Fukuhara, Makoto Maemondo

Cancers 15(17) 2023年8月24日
A retrospective study of the efficacy of combined EGFR‑TKI plus VEGF inhibitor/cytotoxic therapy vs. EGFR‑TKI monotherapy for PD‑L1‑positive EGFR‑mutant non‑small cell lung cancer: North Japan Lung Cancer Study Group 2202.

Minehiko Inomata, Yosuke Kawashima, Ryota Saito, Daisuke Morinaga, Hitomi Nogawa, Masamichi Sato, Yohei Suzuki, Satoru Yanagisawa, Takashi Kikuchi, Daisuke Jingu …

Oncology letters 26(2) 334-334 2023年8月
肺癌効果予測因子非小細胞肺癌に対する殺細胞性抗癌剤・免疫チェックポイント阻害薬併用療法の効果予測因子の探索

木村望, 突田容子, 渋谷里紗, 宮内栄作, 角藤翔, 成田大輔, 斎藤良太, 杉浦久敏

日本呼吸器学会誌 12(増刊) 194-194 2023年3月
Clinical efficacy of amrubicin in patients with small cell lung cancer relapse after first-line treatment including immune checkpoint inhibitors: A retrospective multicenter study (TOPGAN 2021-01).

Shinya Uematsu, Satoru Kitazono, Hisashi Tanaka, Ryota Saito, Yosuke Kawashima, Fumiyoshi Ohyanagi, Takehiro Tozuka, Tsugitomi Ryosuke, Toshio Sakatani, Atsushi Horiike …

Thoracic cancer 14(2) 168-176 2022年11月21日
Durvalumab after chemoradiotherapy for locally advanced non-small cell lung cancer prolonged distant metastasis-free survival, progression-free survival and overall survival in clinical practice.

Takaya Yamamoto, Yoko Tsukita, Yu Katagiri, Haruo Matsushita, Rei Umezawa, Yojiro Ishikawa, Noriyoshi Takahashi, Yu Suzuki, Kazuya Takeda, Eisaku Miyauchi …

BMC cancer 22(1) 364-364 2022年4月4日
Phase I/II study of biweekly nab-paclitaxel in patients with platinum-pretreated non-small cell lung cancer: NJLCG1402.

Eisaku Miyauchi, Hisashi Tanaka, Atsushi Nakamura, Toshiyuki Harada, Taku Nakagawa, Mami Morita, Daisuke Jingu, Tomoya Kuda, Shunichi Gamou, Ryota Saito …

Thoracic cancer 2021年9月14日
Randomized phase 2 study comparing irinotecan versus amrubicin as maintenance therapy after first-line induction therapy for extensive disease small cell lung cancer (HOT1401/NJLCG1401).

Hisashi Tanaka, Yukihiro Hasegawa, Yuka Fujita, Atsushi Nakamura, Eiki Kikuchi, Yasutaka Kawai, Toshiyuki Harada, Naomi Watanabe, Hiroshi Yokouchi, Kazuhiro Usui …

Thoracic cancer 12(14) 2113-2121 2021年7月
ALK-IHC陽性肺腺癌に対してアレクチニブを投与したが奏効せず、後にROS1陽性が判明しクリゾチニブが奏効した1例

杉山初美, 宮内栄作, 齋藤勉, 相澤洋之, 突田容子, 齋藤良太, 佐藤輝幸, 宍倉裕, 杉浦久敏, 齊藤涼子

肺癌 60(7) 1032-1032 2020年12月
Results of the non-small cell lung cancer part of a phase III, open-label, randomized trial evaluating topical corticosteroid therapy for facial acneiform dermatitis induced by EGFR inhibitors: stepwise rank down from potent corticosteroid (FAEISS study, NCCH-1512).

Kazumi Nishino, Yutaka Fujiwara, Yuichiro Ohe, Ryota Saito, Eisaku Miyauchi, Tetsu Kobayashi, Yasuo Nakai, Toshiaki Takahashi, Taro Shibata, Tetsuya Hamaguchi …

Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 29(5) 2327-2334 2020年9月11日査読有り
Phase II Study of Low-Dose Afatinib Maintenance Treatment Among Patients with EGFR-Mutated Non-Small Cell Lung Cancer: North Japan Lung Cancer Study Group Trial 1601 (NJLCG1601).

Atsushi Nakamura, Hisashi Tanaka, Ryota Saito, Aya Suzuki, Toshiyuki Harada, Sumito Inoue, Toru Yamada, Taku Nakagawa, Daisuke Jingu, Shunichi Sugawara

The oncologist 2020年6月19日査読有り
CD45+CD326+ Cells are Predictive of Poor Prognosis in Non-Small Cell Lung Cancer Patients.

Kota Ishizawa, Mie Yamanaka, Yuriko Saiki, Eisaku Miyauchi, Shinichi Fukushige, Tetsuya Akaishi, Atsuko Asao, Takahiro Mimori, Ryota Saito, Yutaka Tojo …

Clinical cancer research : an official journal of the American Association for Cancer Research 25(22) 6756-6763 2019年11月15日査読有り
プラチナ製剤を含む2レジメン以上の治療歴を有する既治療NSCLCに対するnab-PTX単剤隔週投与の第I/II相試験

原田敏之, 宮内栄作, 田中寿志, 中村敦, 中川拓, 盛田麻美, 神宮大輔, 久田友哉, 蒲生俊一, 齊藤良太 …

肺癌 59(6) 797-797 2019年11月
Molecular Mechanism of Cellular Oxidative Stress Sensing by Keap1.

Takafumi Suzuki, Aki Muramatsu, Ryota Saito, Tatsuro Iso, Takahiro Shibata, Keiko Kuwata, Shin-Ichi Kawaguchi, Takao Iwawaki, Saki Adachi, Hiromi Suda …

Cell reports 28(3) 746-758 2019年7月16日査読有り
Pulmonary Lymphatic Perfusion Syndrome.

Taizou Hirano, Naoya Fujino, Kei Takase, Hideki Ota, Rie Tanaka, Ryota Saito, Ayumi Suzuki, Koji Okutomo, Teruyuki Sato, Sakiko Kageyama …

American journal of respiratory and critical care medicine 199(4) 529-530 2019年2月15日査読有り
C151 in KEAP1 is the main cysteine sensor for the cyanoenone class of NRF2 activators, irrespective of molecular size or shape.

Sharadha Dayalan Naidu, Aki Muramatsu, Ryota Saito, Soichiro Asami, Tadashi Honda, Tomonori Hosoya, Ken Itoh, Masayuki Yamamoto, Takafumi Suzuki, Albena T Dinkova-Kostova

Scientific reports 8(1) 8037-8037 2018年5月23日査読有り
The novel Nrf2 inducer TFM-735 ameliorates experimental autoimmune encephalomyelitis in mice.

Chika Higashi, Atsuko Kawaji, Naoto Tsuda, Makiko Hayashi, Ryota Saito, Yoko Yagishita, Takafumi Suzuki, Akira Uruno, Masaki Nakamura, Kazunari Nakao …

European journal of pharmacology 802 76-84 2017年5月5日査読有り
Characterizations of Three Major Cysteine Sensors of Keap1 in Stress Response.

Ryota Saito, Takafumi Suzuki, Keiichiro Hiramoto, Soichiro Asami, Eriko Naganuma, Hiromi Suda, Tatsuro Iso, Hirotaka Yamamoto, Masanobu Morita, Liam Baird …

Molecular and cellular biology 36(2) 271-84 2016年1月15日査読有り
A phase II study of carboplatin and pemetrexed for elderly patients with advanced non-squamous non-small cell lung cancer

Hironari Nishizawa, Atsushi Horiike, Ryota Saito, Fumiyoshi Ohyanagi, Keita Kudo, Noriko Yanagitani, Yuichi Tambo, Satoru Kitazono, Hiroshi Kobayashi, Makoto Nishio

Cancer Treatment and Research Communications 9 100-105 2016年査読有り

もっとみる

MISC

強度変調放射線治療による根治的化学放射線療法後のデュルバルマブ使用経験の報告

突田容子, 宮内栄作, 斎藤良太, 佐藤輝幸, 山本貴也, 片桐佑, 井上彰, 一ノ瀬正和

肺癌 59(6) 674-674 2019年11月
Randomized phase 2 trial comparing amrubicin (A) with re-challenge of platinum doublet (P) in patients (pts) with sensitive-relapsed small-cell lung cancer (SCLC).

Atsushi Nakamura, Akira Inoue, Makoto Maemondo, Yoshiaki Mori, Satoshi Oizumi, Masao Harada, Shingo Takanashi, Naoto Morikawa, Takashi Ishida, Ichiro Kinoshita …

JOURNAL OF CLINICAL ONCOLOGY 32(15) 2014年5月
Phase II study of amrubicin (AMR) combined with carboplatin (CBDCA) for refractory relapsed small cell lung cancer (SCLC): North Japan Lung Cancer Group 0802.

Ryota Saito, Akira Inoue, Shunichi Sugawara, Satoshi Oizumi, Makoto Maemondo, Koichi Okudera, Toshiro Suzuki, Kazuhiro Usui, Masao Harada, Naoto Morikawa …

JOURNAL OF CLINICAL ONCOLOGY 30(15) 2012年5月
Detection of EML4-ALK in serum RNA from lung cancer patients using MassARRAY platform.

Keita Kudo, Makoto Nishio, Kazuko Sakai, Azusa Tanimoto, Toshio Sakatani, Ryota Saito, Kyohei Kaburaki, Noriko Yanagitani, Atsushi Horiike, Fumiyoshi Ohyanagi …

JOURNAL OF CLINICAL ONCOLOGY 30(15) 2012年5月
IMPACT OF THE 7TH EDITION OF TNM CLASSIFICATION (UICC7) IN NON-SURGICAL CASES OF ADVANCED NON-SMALL CELL LUNG CANCER

Noriko Yanagitani, Toshio Sakatani, Ryota Saito, Hisashi Tanaka, Kyohei Kaburaki, Keita Kudo, Atsushi Horiike, Fumiyoshi Ohyanagi, Sachiko Hagiwara, Takeshi Horai …

JOURNAL OF THORACIC ONCOLOGY 6(6) S1167-S1168 2011年6月
PLASMA HOMOCYSTEINE LEVELS ARE ASSOCIATED WITH THE HEMATOLOGICAL TOXICITY OF PEMETREXED EVEN WITH FOLATE SUPPLEMENTATION

Hisashi Tanaka, Atsushi Horiike, Toshio Sakatani, Ryota Saito, Kyohei Kaburaki, Noriko Yanagitani, Keita Kudo, Fumiyoshi Ohyanagi, Sachiko Hagiwara, Takeshi Horai …

JOURNAL OF THORACIC ONCOLOGY 6(6) S1222-S1223 2011年6月
進行肺癌におけるALK陽性肺癌の臨床的特徴

工藤慶太, 竹内賢吾, 酒谷俊夫, 斎藤良太, 鏑木強平, 田中寿志, 柳谷典子, 堀池篤, 大柳文義, 元井紀子 …

肺癌 50(5) 635-635 2010年10月5日
ペメトレキセド療法の血中ホモシステイン値と毒性の相関性の検討

田中寿志, 堀池篤, 酒谷俊雄, 斎藤良太, 鏑木教平, 柳谷典子, 工藤慶太, 大柳文義, 宝来威, 西尾誠人

肺癌 50(5) 531-531 2010年10月
手術不能肺癌症例における新旧TNM病期分類の比較

柳谷典子, 酒谷俊雄, 齋藤良太, 田中寿志, 鏑木教平, 工藤慶太, 大柳文義, 堀池篤, 宝来威, 西尾誠人

肺癌 50(5) 539-539 2010年10月
Streptococcus oralisが原因と考えられた劇症型連鎖球菌感染症の1例

中村敦, 高橋俊明, 久米正晃, 斎藤良太, 村松聡士, 佐藤広規, 庄田三希子, 中嶋壮太, 村上康司, 相澤健太郎 …

秋田県農村医学会雑誌 53(1) 70-70 2007年7月

共同研究・競争的資金等の研究課題

Keap1-Nrf2システムに着目した慢性閉塞性肺疾患の発症メカニズムの解明

日本学術振興会科学研究費助成事業若手研究 2022年4月 - 2025年3月

齋藤良太